Shaping Impact Group’s Post

FirstWord Pharma spoke with Rashme Cardoza, Global Medical Affairs Consultant, formerly at GSK, about the future of pharma’s advisory boards and how their evolution is driving greater collaboration and innovation within the pharmaceutical industry. A few takeaways: 👩💻 Leveraging technology has revolutionized pharma's approach to seeking expertise and insights, allowing for greater accessibility, diversity, real-world evidence, and patient involvement, whilst being flexible and cost-effective. ⚕ This highlights the growing role of Medical Affairs, with a more strategic contribution to overall business decisions. 📏 Engagement metrics, reach, accessibility and decision impact are key to measuring effectiveness of virtual advisory boards. Read the full report here: https://lnkd.in/esktTKcE It was a pleasure interviewing you, Rashme Cardoza!

Happy to secure front page coverage for Dr Sheuli Porkess in PharmaTimes Media Ltd. Dr Porkess discusses how an AI-driven risk methodology, used in healthcare to manage everything from waiting lists to hospital safety, could now help to transform medicines strategies, target pharmaceutical research and enable life sciences policy commitment. Take a read - pages 12-13! John Pinching Carolyn Heaney Katrina Croft Matthew D'Arcy #pharmaceuticals #healthtech #AI

🌟 Exciting insights from our CEO Jenny Ousbey who spoke at the Patient Centricity & Collaboration World Congress earlier this week! 🌍 At the event, Emma Sutcliffe spearheaded a theme of #noexcuses for progress. In that spirit, here are Jenny's six compelling reasons why patient advocacy and engagement are essential for pharmaceutical companies: 1️⃣ Patient engagement boosts participation in clinical trials and improves medicine adherence. 2️⃣ 81% of FDA approvals in 2019 relied on relevant patient experience data. 3️⃣ Engaging patients pre-launch can trim product time to market by 2.5 years. 4️⃣ 90% of doctors equate patient engagement with data, emphasizing the need for further progress. 5️⃣ Investors are increasingly prioritizing patient centricity and engagement in discussions with executives. 6️⃣ Yet, only a few companies have a Chief Patient Officer on their leadership team, indicating room for improvement. As Leonard Kish noted, patient engagement is the blockbuster drug of the century. Let's rally behind it! 💪 Join the movement by participating in the Patient Partnership Index at https://lnkd.in/esSzZQMc. The Association of the British Pharmaceutical Industry (ABPI) Healthcare Communications Association (HCA) #PatientCentricity #Pharmaceuticals #NoExcuses #Leadership

Prasanna Kumar Subbanna will be joining us at #TheMachinecon2024. He is a seasoned physician and business executive with over two decades of distinguished experience in the healthcare and pharmaceutical R&D sectors. With a profound understanding of the global value chain, his expertise spans clinical development, product launches, and bedside care, underscoring a comprehensive approach to healthcare innovation and patient outcomes. He will share his insights on "The Role of #GCCs in Healthcare Innovation" in an interesting panel Discussion. Novo Nordisk

🩺💼 Elevate Your Healthcare Strategy with MHN's Physicians Panel! 💡💊 Plan your project here: https://lnkd.in/er-_cxKu Hey pharmaceutical pioneers and healthcare marketers! 📣 Seeking the perfect platform to test your latest medicines, marketing campaigns, and healthcare innovations? Look no further than MHN's renowned Physicians Panel! Our panel boasts a diverse array of medical experts from various specialties, offering unparalleled insights into the dynamic healthcare landscape. From groundbreaking treatments to cutting-edge marketing strategies, our panelists provide invaluable feedback to help you refine your approach and drive success in the competitive healthcare market. With MHN, you'll have access to a network of leading physicians and clinicians who are dedicated to advancing patient care and medical innovation. Whether you're launching a new medication or exploring innovative treatment options, our Physicians Panel offers a robust platform to gather actionable insights and make informed decisions. Don't miss out on this opportunity to collaborate with top-tier healthcare professionals and elevate your healthcare strategy to new heights! Reach out to MHN today and discover how our Physicians Panel can empower your success in the ever-evolving healthcare landscape. #MHNInsights #PhysiciansPanel #HealthcareInnovation #Pharmaceuticals #MedicalExperts 🏥  #RepresentativeSamples #MarketResearch 🚀🔍 #QualitativeResearch #QuantitativeResearch #MHN #MHNInsights

To continue the accomplishments of yesterdays post : 4️⃣ Distribution: EIMC played a pivotal role in ensuring broad market coverage, supplying medical institutions, governmental entities, and pharmacies nationwide. Our unwavering commitment to efficient distribution has made a significant impact on healthcare accessibility across the country. 5️⃣ Specialty Pharmacy: To further enhance access to our life-changing medications, we utilized the extensive networks of Ali&Ali and Al'Image chains. This strategic collaboration enabled us to cater to the needs of Greater Cairo and extend our reach to pharmacies nationwide. We are immensely proud of the milestones we achieved and the positive impact we made on patients' lives. At Al'Image Pharma, we are dedicated to revolutionizing the pharmaceutical industry, fostering innovation, and improving healthcare outcomes. #AlImagePharma #PharmaceuticalIndustry #HealthcareInnovation #SupplyChainRevolution #OncologyTreatment #globalhealthcare

👨⚕️💼 Tap into Expertise with MHN's Physicians Panel! 💊💡 Plan your project here: https://lnkd.in/er-_cxKu Attention pharmaceutical brands and healthcare innovators! 📣 Are you searching for a reliable platform to test and refine your new marketing strategies, medicines, and products? Look no further than MHN's esteemed Physicians Panel! Our panel comprises a diverse network of medical professionals from various specialties and backgrounds, offering unparalleled expertise and insights into the ever-evolving healthcare landscape. Whether you're launching a new medication, exploring innovative treatment options, or fine-tuning your marketing campaigns, our Physicians Panel provides a robust platform to gather valuable feedback and make informed decisions. With MHN, you can engage with leading physicians, clinicians, and healthcare experts who are at the forefront of medical advancements and patient care. Our panelists offer invaluable perspectives on efficacy, safety, and patient outcomes, helping you navigate regulatory requirements and market dynamics with confidence. Don't miss out on this opportunity to collaborate with top-tier healthcare professionals and leverage their expertise to drive innovation and success in your industry. Reach out to MHN today to learn more about how our Physicians Panel can help you test new marketing strategies, medicines, and products and stay ahead in the competitive healthcare market! #MHNInsights #PhysiciansPanel #HealthcareInnovation #Pharmaceuticals #MedicalExperts 💉  #RepresentativeSamples #MarketResearch 🚀🔍 #QualitativeResearch #QuantitativeResearch #MHN #MHNInsights

𝘾𝙚𝙡𝙚𝙗𝙧𝙖𝙩𝙞𝙣𝙜 𝙒𝙤𝙧𝙡𝙙 𝙋𝙝𝙖𝙧𝙢𝙖𝙘𝙞𝙨𝙩𝙨 𝘿𝙖𝙮: 𝘼 𝙏𝙧𝙞𝙗𝙪𝙩𝙚 𝙩𝙤 𝙄𝙣𝙣𝙤𝙫𝙖𝙩𝙞𝙤𝙣 𝙖𝙣𝙙 𝘿𝙚𝙙𝙞𝙘𝙖𝙩𝙞𝙤𝙣 𝙞𝙣 𝙃𝙚𝙖𝙡𝙩𝙝𝙘𝙖𝙧𝙚 💊   On this World Pharmacists Day, Kreglinger proudly salutes the pharmacists who play a pivotal role in advancing global health. As a trusted partner in the pharmaceutical industry, we recognize the dedication, expertise, and innovation that pharmacists bring to the table every day.   Pharmacists are not just the gatekeepers of medications; 𝙩𝙝𝙚𝙮 𝙖𝙧𝙚 𝙘𝙧𝙪𝙘𝙞𝙖𝙡 𝙩𝙤 𝙚𝙣𝙨𝙪𝙧𝙞𝙣𝙜 𝙩𝙝𝙖𝙩 𝙥𝙖𝙩𝙞𝙚𝙣𝙩𝙨 𝙧𝙚𝙘𝙚𝙞𝙫𝙚 𝙩𝙝𝙚 𝙗𝙚𝙨𝙩 𝙥𝙤𝙨𝙨𝙞𝙗𝙡𝙚 𝙘𝙖𝙧𝙚. Their profound knowledge of drug interactions, patient counseling, and personalized medicine makes them indispensable in today’s healthcare ecosystem.   At Kreglinger, we are committed to supporting pharmacists by providing high-quality ingredients, innovative solutions, and continuous education that empower them to perform at their best. Together, we are driving forward a future where healthcare is more personalized, accessible, and effective.   On this special day, we extend our gratitude to pharmacists worldwide for their unwavering commitment to improving lives. 𝗬𝗼𝘂𝗿 𝘄𝗼𝗿𝗸 𝗶𝗻𝘀𝗽𝗶𝗿𝗲𝘀 𝘂𝘀 𝘁𝗼 𝗰𝗼𝗻𝘁𝗶𝗻𝘂𝗲 𝗽𝘂𝘀𝗵𝗶𝗻𝗴 𝘁𝗵𝗲 𝗯𝗼𝘂𝗻𝗱𝗮𝗿𝗶𝗲𝘀 𝗼𝗳 𝘄𝗵𝗮𝘁’𝘀 𝗽𝗼𝘀𝘀𝗶𝗯𝗹𝗲 𝗶𝗻 𝗽𝗵𝗮𝗿𝗺𝗮𝗰𝗲𝘂𝘁𝗶𝗰𝗮𝗹 𝗶𝗻𝗻𝗼𝘃𝗮𝘁𝗶𝗼𝗻.   #WorldPharmacistsDay #PharmaceuticalExcellence #Kreglinger #HealthcareInnovation #PharmacistsRock

Exciting developments are underway in Spain's healthcare sector as a more systematic approach to pharmaceutical evaluation and decision-making is being introduced. The upcoming implementation of the new Royal Decree on Health Technology Assessment promises a structured three-tier model, ensuring clarity and separation between evaluation, positioning, and decision phases. This innovative framework aims to streamline the processes and enhance transparency in healthcare decisions. In a parallel stride, the Health and Social Consortium of Catalonia, in collaboration with Lyfegen, is pioneering new value-based purchasing models. This initiative not only underscores Spain's commitment to progressive healthcare strategies but also leverages real-world data to ensure cost-effectiveness and patient-centric care. These advancements signify a pivotal transformation in managing healthcare evaluations and pharmaceutical pricing, promising better outcomes for all stakeholders involved. Learn more about the new assessment system (Spanish): https://lnkd.in/dtGENv2f Read our press release here: https://lnkd.in/dnnXjtWS Thank you for your inspiring coverage Neil Grubert. #HealthcareInnovation #ValueBasedHealthcare #SpanishHealthcare

#PatientEngagement : From Nice-to-Have to Must-Have at #ReutersPharma 2024 At #ReutersPharma 2024 in Barcelona, I had the opportunity to attend, with my colleagues, Marta Garcia Manrique and Alexandre Jaegly,   key discussions surrounding the crucial topic of #PatientEngagement. Key Takeaways : -> #Patientengagement is no longer a "nice-to-have" but a "must-have" for pharmaceutical companies. The industry is moving beyond simply checking a box to demonstrating the strategic value and commercial benefits of patient engagement initiatives. -> Measuring and proving the impact of #patientengagement efforts is essential. Companies need to establish clear metrics and frameworks to track the effectiveness of their programs and showcase their contribution to improved patient outcomes and business objectives. ->Building impactful #patientengagement capabilities requires a cross-functional approach. Collaboration between departments such as commercial, marketing, medical affairs, and R&D is crucial for developing and executing successful patient engagement strategies. Overall, #ReutersPharma 2024 reinforced the notion that #patientengagement is not just a buzzword but a critical component of the pharmaceutical industry's future success. By embracing patient-centricity, companies can build stronger relationships with patients, improve health outcomes, and drive business growth. #pharma #healthcare #patientcentricity #WeAreServier #MovedByYou